IMARC Group, a leading market research company, has recently releases report titled “Vaginal Slings Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Vaginal Slings market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big Is The Vaginal Slings Market?
The global vaginal slings market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028.
What are Vaginal Slings?
Vaginal slings refer to the surgeries treating stress urinary incontinence among women, which includes urine leakage caused by raised pressure in the abdomen. They aid in closing the urethra and bladder neck with a piece of artificial mesh or tissue underneath the urethra. Vaginal slings offer various advantages to patients, such as faster post-operative recovery time, a small vaginal incision, and no requirement for an abdominal incision and hospital stay. As a result, these surgeries are widely carried out in clinics, hospitals, and ambulatory surgical centers across the globe.
What Are The Growth Prospects And Trends In The Vaginal Slings Industry?
The escalating prevalence of stress urinary incontinence in women, owing to pregnancy, childbirth, and menopause, which may affect the urinary tract and surrounding muscles, and the rising female geriatric population across the globe are among the primary factors driving the vaginal slings market. Besides this, the increasing awareness in individuals toward the benefits of this treatment compared to conventional surgeries is further augmenting the market growth. Moreover, the elevating number of gynecological and urological centers to cater to the demand for vaginal sling procedures is also catalyzing the global market.
Apart from this, the high cases of hysterectomy, on account of uterine fibroids, which cause pain, bleeding, or other problems, and the launch of several policies by the government bodies across countries to improve the healthcare infrastructure are acting as significant growth-inducing factors. Furthermore, the leading players are extensively investing in research and development (R&D) activities for the introduction of technologically advanced surgical products, which is anticipated to propel the vaginal slings market over the forecasted period.
What Is Included In Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Type:
- Conventional Vaginal Slings
- Advanced Vaginal Slings
Breakup by Product Type:
- Transobturator Slings
- Tension-free Vaginal Tape Sling
- Others
Breakup by Type of Urinary Incontinence:
- Stress Urinary Incontinence
- Urge Urinary Incontinence
- Mixed Urinary Incontinence
Breakup by End User:
- Hospitals
- Ambulatory Surgery Centers
- Other
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who Are The Key Players Operating In The Industry?
The report covers the major market players including:
- M.I. GmbH
- Braun Melsungen AG
- Betatech Medical
- Boston Scientific Corporation
- Caldera Medical
- Coloplast A/S
- Cousin Biotech
- Medtronic plc
- Neomedic International
- and Promedon GmbH.
Ask Analyst For Customization And Browse Full Report With TOC & List Of Figure: https://www.imarcgroup.com/vaginal-slings-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
